Search bioRxiv⌕ Search

Biology subjects

Jeffs, M.

Publications and source records attributed to Jeffs, M..

2 recordsLinked to original sources

Contributions of β-lactamase substrate specificity and outer membrane permeability to the antibiotic sheltering of β-lactam-susceptible bacteria

The use of {beta}-lactam antibiotics is threatened by antibiotic resistant bacteria that produce {beta}-lactamases. These enzymes not only protect the bacteria that produce them but also shelter other bacteria in the same environment that would otherwise be susceptible. While this phenomenon is of clinical significance, many of the factors that contribute to {beta}-lactamase-mediated antibiotic sheltering have not been well-studied. We report the development of a luminescence assay to directly monitor the survival of {beta}-lactam-susceptible bacteria in the presence of {beta}-lactamase-producing bacteria and {beta}-lactam antibiotics. This method provides a rapid and scalable means of quantifying antibiotic sheltering in mixed microbial populations. We applied this assay to investigate the contributions of several factors to sheltering, including the class of {beta}-lactam, the substrate specificity of the {beta}-lactamase, and the cell wall permeability of the {beta}-lactamase-producing bacterium. Our results show that the extent of sheltering that occurs depends greatly on the particular combination of {beta}-lactam and {beta}-lactamase, and also on the ability of a {beta}-lactamase to access its {beta}-lactam substrate.

microbiology↗

Development of a Whole-Cell Biosensor for β-Lactamase Inhibitor Discovery

The clinical utility of the {beta}-lactam antibiotics has been endangered by the production of {beta}-lactamases by {beta}-lactam-resistant pathogenic bacteria such as Escherichia coli, Pseudomonas aeruginosa and Acinetobacter baumannii. Collectively, these enzymes can degrade every clinically available {beta}-lactam, jeopardizing antimicrobial therapy. Although extensive efforts have been made to develop {beta}-lactamase inhibitors, inhibitor-resistant {beta}-lactamases emerge rapidly. In addition, there are currently no clinically available inhibitors against the metallo-{beta}-lactamases, a group of {beta}-lactamases of great global concern. To further inhibitor discovery efforts, new assays are required to assess inhibitor efficacy, particularly in a cellular context. We report the development of a whole-cell E. coli biosensor which can quantify {beta}-lactamase inhibition in a cellular context. Upon administration of an effective inhibitor, a {beta}-lactam is rescued from {beta}- lactamase-catalyzed degradation, resulting in the emission of a luminescent signal by the biosensor. This platform was validated using a panel of clinically relevant {beta}-lactamases and was applied to quantitatively study the potency of a selection of currently used and reported {beta}-lactamase inhibitors. This rapid method can account for factors like membrane permeability and can be employed to identify new {beta}-lactamase inhibitors.

microbiology↗